Embecta Corp.

Embecta Corp.

EMBCV

$33.33

Updated: 24/09/2026, 22:15:28

Market Cap
$1.91B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US

No historical data available

Company Profile

Embecta Corp. operates as a medical device company, primarily dedicated to improving the health and overall well-being of individuals living with diabetes. Its diverse product range encompasses essential items like pen needles, syringes, and various safety devices, alongside digital tools specifically designed to assist with diabetes self-management. The company distributes its offerings mainly through wholesalers and distributors, reaching customers across the United States and internationally. Embecta Corp. was established in 1924 and is headquartered in Parsippany, New Jersey.

USD
NASDAQ
Employees: 2,029
https://www.embecta.com
Asset Summaries
Latest generated summaries for EMBCV

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for EMBCV.
Share price
$33.33
Market cap
$1.91B
Exchange
NASDAQ
Currency
USD
CEO
N/A
Employees
2,029
IPO date
21/03/2022
Beta
0
Last dividend
$0.00
Day range
$33.33 – $38.21
52-week range
$27.20 – $49.00
1-day performance
-9.33%
1-year performance
22.54%
Current drawdown (1Y)
-31.98%
CIK
0001872789
CUSIP
N/A
ISIN
N/A
Created
07/12/2025, 03:46:06
Last update
24/09/2026, 22:15:28

Track Embecta Corp. with an AI analyst

See which prediction-market events move EMBCV, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to EMBCV from your Railway `news_articles` table.

No news found for this symbol.